New York State Common Retirement Fund
VBIV

New York State Common Retirement Fund’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

New York State Common Retirement Fund’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-54
Closed -$178 – 3400
2023
Q2 		$178 Sell
54
-4,283
-99% -$12.9K ﹤0.01% 3404
2023
Q1 		$39.4K Hold
4,337
– – ﹤0.01% 3042
2022
Q4 		$50.9K Hold
4,337
– – ﹤0.01% 3087
2022
Q3 		$92K Buy
4,337
+10
+0.2% +$270 ﹤0.01% 3043
2022
Q2 		$105K Sell
4,327
-10
-0.2% -$340 ﹤0.01% 3037
2022
Q1 		$216K Buy
4,337
+3
+0.1% +$148 ﹤0.01% 2797
2021
Q4 		$304K Sell
4,334
-14
-0.3% -$1.18K ﹤0.01% 2704
2021
Q3 		$406K Sell
4,348
-1,017
-19% -$96.6K ﹤0.01% 2582
2021
Q2 		$539K Buy
5,365
+425
+9% +$41.4K ﹤0.01% 2563
2021
Q1 		$461K Sell
4,940
-473
-9% -$48K ﹤0.01% 2495
2020
Q4 		$447K Buy
5,413
+1,150
+27% +$98.1K ﹤0.01% 2398
2020
Q3 		$366K Sell
4,263
-980
-19% -$114K ﹤0.01% 2366
2020
Q2 		$488K Buy
5,243
+2,210
+73% +$122K ﹤0.01% 2233
2020
Q1 		$86K Hold
3,033
– – ﹤0.01% 2820
2019
Q4 		$126K Hold
3,033
– – ﹤0.01% 2931
2019
Q3 		$43K Hold
3,033
– – ﹤0.01% 3169
2019
Q2 		$106K Buy
+3,033
New +$164K ﹤0.01% 3081
2018
Q2 		– Sell
-1,150
Closed -$121K – 3227
2018
Q1 		$121K Hold
1,150
– – ﹤0.01% 2915
2017
Q4 		$147K Buy
1,150
+877
+321% +$108K ﹤0.01% 2884
2017
Q3 		$32K Hold
273
– – ﹤0.01% 3078
2017
Q2 		$36K Buy
+273
New +$36.8K ﹤0.01% 3158

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York State Common Retirement Fund's VBIV Position: Q3 2023 in Review

New York State Common Retirement Fund sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 54 shares — an estimated $178 sold.

New York State Common Retirement Fund first reported a position in VBIV in Q2 2017 and held it in 21 quarters. The position peaked at $539K in Q2 2021. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

  • New York State Common Retirement Fund reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
  • New York State Common Retirement Fund sold 54 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $178.
  • New York State Common Retirement Fund first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2017 and held it in 21 quarters.
  • New York State Common Retirement Fund's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $539K in Q2 2021.
  • 37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on New York State Common Retirement Fund's 13F filing for Q3 2023, filed 7 Nov 2023.